JP Morgan Chase’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-20,000
| Closed | -$9.34M | – | 7685 |
|
|
2025
Q4 | $9.34M | Hold |
20,000
| – | – | ﹤0.01% | 2748 |
|
|
2025
Q3 | $8.52M | Buy |
+20,000
| New | +$7.75M | ﹤0.01% | 2870 |
|
|
2025
Q2 | – | Sell |
-2,900
| Closed | -$1M | – | 7317 |
|
|
2025
Q1 | $1M | Sell |
2,900
-18,500
| -86% | -$5.95M | ﹤0.01% | 4345 |
|
|
2024
Q4 | $6.42M | Hold |
21,400
| – | – | ﹤0.01% | 3122 |
|
|
2024
Q3 | $8.7M | Hold |
21,400
| – | – | ﹤0.01% | 2728 |
|
|
2024
Q2 | $6.88M | Sell |
21,400
-11,600
| -35% | -$3.77M | ﹤0.01% | 2782 |
|
|
2024
Q1 | $11M | Sell |
33,000
-8,600
| -21% | -$2.63M | ﹤0.01% | 2388 |
|
|
2023
Q4 | $11.3M | Buy |
41,600
+10,900
| +36% | +$2.69M | ﹤0.01% | 2351 |
|
|
2023
Q3 | $7.55M | Buy |
30,700
+19,100
| +165% | +$5.23M | ﹤0.01% | 2514 |
|
|
2023
Q2 | $3.52M | Buy |
11,600
+11,500
| +11,500% | +$3.2M | ﹤0.01% | 3134 |
|
|
2023
Q1 | $26K | Sell |
100
-10,100
| -99% | -$2.57M | ﹤0.01% | 5910 |
|
|
2022
Q4 | $2.45M | Buy |
10,200
+6,400
| +168% | +$1.43M | ﹤0.01% | 3409 |
|
|
2022
Q3 | $698K | Sell |
3,800
-47,400
| -93% | -$9.44M | ﹤0.01% | 4255 |
|
|
2022
Q2 | $8.61M | Buy |
51,200
+47,400
| +1,247% | +$10.2M | ﹤0.01% | 2291 |
|
|
2022
Q1 | $952K | Sell |
3,800
-23,400
| -86% | -$5.88M | ﹤0.01% | 4311 |
|
|
2021
Q4 | $6.99M | Hold |
27,200
| – | – | ﹤0.01% | 2761 |
|
|
2021
Q3 | $6.6M | Buy |
27,200
+4,000
| +17% | +$978K | ﹤0.01% | 2787 |
|
|
2021
Q2 | $4.8M | Buy |
+23,200
| New | +$4.73M | ﹤0.01% | 3079 |
|
|
2021
Q1 | – | Sell |
-91,500
| Closed | -$15M | – | 6177 |
|
|
2020
Q4 | $15M | Sell |
91,500
-25,000
| -21% | -$3.66M | ﹤0.01% | 1865 |
|
|
2020
Q3 | $14M | Hold |
116,500
| – | – | ﹤0.01% | 1763 |
|
|
2020
Q2 | $11.3M | Sell |
116,500
-86,000
| -42% | -$8.94M | ﹤0.01% | 1801 |
|
|
2020
Q1 | $18.2M | Buy |
202,500
+127,500
| +170% | +$16.5M | ﹤0.01% | 1315 |
|
|
2019
Q4 | $11.1M | Buy |
75,000
+50,000
| +200% | +$6.71M | ﹤0.01% | 2036 |
|
|
2019
Q3 | $3.01M | Sell |
25,000
-84,000
| -77% | -$10.9M | ﹤0.01% | 3124 |
|
|
2019
Q2 | $14.6M | Buy |
+109,000
| New | +$13.8M | ﹤0.01% | 1804 |
|
|
2018
Q4 | – | Sell |
-50,000
| Closed | -$6.96M | – | 5773 |
|
|
2018
Q3 | $6.96M | Hold |
50,000
| – | – | ﹤0.01% | 2489 |
|
|
2018
Q2 | $5.13M | Hold |
50,000
| – | – | ﹤0.01% | 2663 |
|
|
2018
Q1 | $4.85M | Sell |
50,000
-59,900
| -55% | -$5.81M | ﹤0.01% | 2603 |
|
|
2017
Q4 | $9.65M | Hold |
109,900
| – | – | ﹤0.01% | 2155 |
|
|
2017
Q3 | $8.69M | Sell |
109,900
-440,400
| -80% | -$35.4M | ﹤0.01% | 2105 |
|
|
2017
Q2 | $48M | Buy |
+550,300
| New | +$46.6M | 0.01% | 926 |
|
|
2016
Q1 | – | Sell |
-284,300
| Closed | -$19.2M | – | 4783 |
|
|
2015
Q4 | $19.2M | Buy |
284,300
+61,400
| +28% | +$4.28M | ﹤0.01% | 1354 |
|
|
2015
Q3 | $17.2M | Sell |
222,900
-212,100
| -49% | -$18.8M | ﹤0.01% | 1364 |
|
|
2015
Q2 | $39.5M | Buy |
435,000
+430,640
| +9,877% | +$34.5M | 0.01% | 1008 |
|
|
2015
Q1 | $328K | Buy |
+4,360
| New | +$313K | ﹤0.01% | 3671 |
|
Other funds holding HCA
VCM
VPM
JP Morgan Chase's HCA Position: Q1 2026 in Review
JP Morgan Chase increased its HCA Healthcare (HCA) stake by 4.4% in Q1 2026, buying an estimated $51.7M and bringing the position to 2,461,975 shares worth $1.15B. The position accounts for 0.07% of the portfolio, ranked #240.
JP Morgan Chase first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.35B in Q2 2023. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- JP Morgan Chase held 2,461,975 shares of HCA Healthcare worth $1.15B as of Q1 2026.
- JP Morgan Chase bought 102,755 HCA Healthcare shares in Q1 2026, an estimated $51.7M.
- HCA Healthcare made up 0.07% of JP Morgan Chase's portfolio in Q1 2026, its #240 holding.
- JP Morgan Chase first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's HCA Healthcare position peaked at $1.35B in Q2 2023.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.